Sharon Mates
CIK 1585699 · Chairman and CEO · last filed 2026-05-04
Sharon Mates is a Chairman and CEO who has filed 59 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for SPTX, was dated May 4, 2026. Across all open-market trades the lifetime net is −$83.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
59
-$83.58M
Holdings By Company
Recent Filings
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-04 | SPTX | Grant (A) | — | $0 | EDGAR |
| 2026-01-26 | BNTC | Grant (A) | — | $0 | EDGAR |
| 2025-12-03 | BNTC | Grant (A) | — | $0 | EDGAR |
| 2025-11-07 | BNTC | Grant (A) | — | $0 | EDGAR |
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | −1,135,235 | -$149.85M | EDGAR |
| 2025-03-31 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Gift (G) | — | $0 | EDGAR |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +31,301 | -$3.93M | EDGAR |
| 2025-03-04 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +17,991 | -$2.18M | EDGAR |
| 2025-02-04 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +15,614 | -$1.93M | EDGAR |
| 2024-12-06 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$7.42M | EDGAR |